•  Nitric Oxide
  •  Products
  •  Innovation
  •  Investors
  •  Connect

Nu-Med Plus

  •  Nitric Oxide
  •  Products
  •  Innovation
  •  Investors
  •  Connect

Patent filed for Nitric Oxide Delivery Device that is comparable to inhalers for single or short-term usage

Posted on January 7, 2020
Posted in Investor News

Post navigation

Nu-Med Plus Presents at the 147th National Investment Banking Association Conference on November 12-13, 2019 in New York City
Nu-Med Plus Closely Monitoring Outcomes on Two New Human Clinical Trials Using Inhaled Nitric Oxide in Treatment of COVID-19

Connect

Jeff Robins | CEO
jeff@nu-medplus.com
801.746.3570
LinkedIn
Twitter

Offices

Corporate 455 E. 500 S.
Suite #203
Salt Lake City UT, 84111

Lab 1266 S 1380 W
Orem UT, 84111

News

Stay Up to Date On Nu-Med Plus News

Legal

SEC Documents Shareholder Letters Privacy Policy

Crunchbase

Profile

© 2021 Nu-Med Plus All Rights Reserved

Site designed + built by Wildern